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Abstract: Hydrogen sulfide (H2S) is an endogenously produced signaling molecule. The enzymes
3-mercaptopyruvate sulfurtransferase (MST), partly localized in mitochondria, and the inner
mitochondrial membrane-associated sulfide:quinone oxidoreductase (SQR), besides being respectively
involved in the synthesis and catabolism of H2S, generate sulfane sulfur species such as persulfides and
polysulfides, currently recognized as mediating some of the H2S biological effects. Reprogramming
of H2S metabolism was reported to support cellular proliferation and energy metabolism in cancer
cells. As oxidative stress is a cancer hallmark and N-acetylcysteine (NAC) was recently suggested to
act as an antioxidant by increasing intracellular levels of sulfane sulfur species, here we evaluated
the effect of prolonged exposure to NAC on the H2S metabolism of SW480 colon cancer cells. Cells
exposed to NAC for 24 h displayed increased expression and activity of MST and SQR. Furthermore,
NAC was shown to: (i) persist at detectable levels inside the cells exposed to the drug for up to 24 h
and (ii) sustain H2S synthesis by human MST more effectively than cysteine, as shown working on
the isolated recombinant enzyme. We conclude that prolonged exposure of colon cancer cells to NAC
stimulates H2S metabolism and that NAC can serve as a substrate for human MST.
Keywords: hydrogen sulfide; sulfane sulfur species; enzymatic activity assays; protein expression
levels; antioxidants; colorectal cancer
1. Introduction
Hydrogen sulfide (H2S) is an endogenously produced signaling molecule involved in the
regulation of several physiological processes, such as blood flow, inflammation, neurotransmission,
apoptosis, redox homeostasis, energy metabolism and stress response [1–3]. The signaling function
of H2S is mainly accomplished by mediating cysteine thiol persulfidation of target proteins [3–6].
Recently, protein persulfidation has emerged as a physiologically relevant modification taking place
both during protein synthesis and post-translationally in a considerable fraction of the proteome in
mammalian cells [6,7]. Along with thiosulfate, persulfides and polysulfides generated from proteins
or low-molecular-weight thiol-containing molecules are H2S-derived species containing zero-valent
sulfur (S0), commonly referred to as “sulfane sulfur”. It was recently demonstrated that these species
are not only much more abundant in the cell than previously thought but also, due to their elevated
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nucleophilicity [8], more reactive with e.g., protein thiols or reactive oxygen species (ROS) than
H2S or their parental thiol compounds [9]. Therefore, many of the biological effects attributed to
H2S are currently believed to be mediated by sulfane sulfur species [10–13], whose antioxidant and
cytoprotective action has been clearly established (reviewed e.g., in [14]). Moreover, sulfane sulfur
species like persulfides have an increased affinity for exogenous toxins with respect to their thiol
counterparts [15–17].
Steady-state levels of H2S and related species in blood and tissues are kept in balance through a
tight regulation of H2S biosynthesis and catabolism [18]. In mammals, H2S is enzymatically produced
by the two predominantly cytosolic enzymes cystathionine β-synthase (CBS) and cystathionine γ-lyase
(CSE) [4] from the transsulfuration pathway and by 3-mercaptopyruvate sulfurtransferase (MST) [19].
Two isoforms of MST have been reported: MST-1, exclusively localized in the cytosol (35 kDa), and
MST-2, present both in the cytosol and mitochondria (33 kDa) [20]. MST converts into pyruvate the
3-mercaptopyruvate (3MP) generated by cysteine aminotransferase, yielding a persulfidated Cys248
(human MST numbering) at the protein active site. The sulfane sulfur atom is then transferred from
the persulfidated protein to an acceptor—such as cysteine (Cys), homocysteine, glutathione (GSH),
dihydrolipoic acid or thioredoxin [19,21]—leading to the formation of the corresponding persulfide
(R-SSH) [19], that can eventually release H2S. MST is therefore a recognized source of both H2S and
sulfane sulfur species in the cell. Unlike H2S biosynthesis, which takes place both at the cytosolic and
mitochondrial level, H2S catabolism occurs essentially in the mitochondrion, where sulfide:quinone
oxidoreductase (SQR)—a flavoenzyme associated to the inner membrane—catalyzes the oxidation of
H2S. The reaction leads to formation of a protein-bound persulfide [22,23] that in turn can donate its
sulfane sulfur atom to sulfite or, more likely, GSH, yielding thiosulfate [24] or glutathione persulfide
(GSSH), respectively [25]. SQR is thus another intracellular source of sulfane sulfur species. As
SQR uses coenzyme Q as the acceptor of the electrons derived from H2S oxidation, SQR-mediated
breakdown of H2S stimulates oxidative phosphorylation and, thus, ATP synthesis, which makes
H2S the first known inorganic substrate of the mitochondrial electron transport chain [26,27]. This
mitochondrial sulfide oxidizing activity varies considerably between different cell types, ranging from
undetectable in neuroblastoma cells to high in colonocytes [28], the latter being physiologically exposed
to the high H2S levels produced by the gut microbiota [29]. Indeed, Libiad and co-authors have recently
demonstrated that colonic crypts at the host-microbiota interface display an apical localization of H2S
oxidation pathway enzymes, whereas this localization pattern is lost in the epithelium of colorectal
cancer [30].
Several human pathologies, including neurodegenerative, cardiovascular and oncological diseases,
are known to be associated with altered H2S metabolism (reviewed in [2,6]), and the enzymes responsible
for H2S biosynthesis are currently recognized as potential pharmacological targets [31–33]. H2S and
related species, including sulfane sulfur species, seem to play a major role in cancer biology [34,35]. In
colorectal cancer cell lines, CBS-derived H2S was suggested to support cellular proliferation, promote
angiogenesis and maintain cell energy metabolism by stimulating both oxidative phosphorylation
and glycolysis [36]. Accordingly, silencing or pharmacological inhibition of CBS significantly reduced
cellular proliferation and migration, and tumor xenograft growth [36]. Furthermore, increased
expression of CBS and CSE was documented in different cancer types, such as colorectal, ovarian,
breast, prostate and melanoma, and was shown to contribute to cancer progression, energy metabolism
and drug resistance [35,37,38]. MST too was found to be upregulated in different cancer types, namely,
colorectal cancer [39], renal carcinoma [40], astrocytoma and melanoma [41]. However, the studies
on the role of MST in cancer are scarcer and only in recent years MST, with its ability to produce
sulfane sulfur species and its partial mitochondrial localization [2], was proposed as a potential target
in cancer biology [42]. Recently, Libiad and colleagues reported increased SQR expression in colon
cancer patient samples relatively to the surrounding normal tissue, and found a correlation between
increased SQR expression and the degree of malignancy in human colorectal cancer tissues and cell
lines [30]. Moreover, in the SW480 colorectal cancer cell line, an increase in mitochondrial levels of
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SQR has been proposed to afford an adaptive response upon exposure to hypoxia, a common feature
within the tumor microenvironment [43].
The association between altered mitochondrial metabolism, dysregulated cell redox homeostasis
and carcinogenesis is well documented (reviewed in [44]). The mitochondrial respiratory chain is a
major source of ROS which are known to have opposite effects on cancer development, depending on
their abundance in the cell. While at lower levels ROS can promote cancer survival and progression
by causing DNA damage and activating pro-oncogenic signaling pathways [45], at excessively high
levels they can induce cell death [46]. Common anticancer drugs owe their efficacy, but also their
unwanted side effects, to their ability to generate oxidative stress in cancerous as well as in healthy
tissues [47–49]. Therefore, targeting the ROS signaling pathways and redox mechanisms involved in
cancer development was suggested as a potential strategy to prevent both cancer formation and the
adverse effects of antitumoral drugs [50]. However, it is still controversial whether supplementation of
antioxidants has an impact on limiting cancer incidence or the side effects of chemotherapy. Clinical
trials have shown that antioxidants may not be beneficial and might even produce adverse effects
in terms of cancer prevention and treatment (reviewed in [51–53]). One of the most widely used
antioxidant drug is N-acetylcysteine (NAC), which has been extensively studied not only for its ROS
scavenging action [54], but also (unfortunately, with rather disappointing results) for its presumed
cytoprotective effects against anticancer drugs [55,56] and cancer preventive action [57–59]. Despite
the wide use of NAC, the molecular mechanisms underlying the antioxidant action of this drug are
not yet fully clear. Although it is generally accepted that NAC exerts its effects acting as a precursor
of Cys and, thus, in turn, of GSH, it seems that the rate of intracellular deacetylation of NAC to Cys
is insufficient to sustain increased GSH biosynthesis [60]. Accordingly, some studies have shown
that NAC supplementation, while providing protection against oxidative stress, does not affect GSH
levels [61]. Recently, Ezerina et al. proposed that NAC-derived Cys enhances mitochondrial levels of
sulfane sulfur species and suggested that these species are the actual mediators of the antioxidants
effects of NAC [62]. This study prompted us to investigate the effect of NAC on H2S metabolism in
colorectal cancer cells. By combining work on the SW480 cell line and on recombinant human MST,
we observed that NAC not only promotes increased expression and activity of MST and SQR, both
involved in the production of sulfane sulfur species, but is also an effective substrate for MST.
2. Materials and Methods
2.1. Materials
The human colon cancer cell line SW480 was purchased from the American Type Culture Collection
(ATCC No. CCL228™). Acetyl coenzyme A (A2056), 7-azido-4-methylcoumarin (7AzC, L511455),
reduced β-nicotinamide adenine dinucleotide (NADH, disodium salt, N8129), Dulbecco’s Modified
Eagle Medium (DMEM) cell culture media (D6546), the cell lysis reagent CelLytic™MT (C2978),
coenzyme Q1 (CoQ1, C7956), d-lactic dehydrogenase (LDH, L2395), 5,5′-dithiobis-(2-nitrobenzoic acid)
(DTNB, D8130), l-cysteine (Cys, C1276), N-acetylcysteine (NAC, A7250), metaphosphoric acid (239275),
2-mercaptoethanol (805740), sodium 3-mercaptopyruvate dihydrate (3MP, 90374), N-ethylmaleimide
(NEM, 34115-M), oxaloacetate (O7753), perchloric acid (PCA, 77232), protease inhibitor cocktail (P8340),
rabbit polyclonal antibody against human SQR (HPA017079) and CBS (SAB1411562), anti-rabbit
peroxidase secondary antibody (A6154), rotenone (R8875), sodium sulfide nonahydrate (Na2S·9H2O,
431648), sodium sulfite (S0505) were purchased from Sigma (Saint Louis, MO, USA). The bicinchoninic
acid assay (BCA) kit and rabbit polyclonal antibody against human MST (PA528779) were purchased
from Thermo Fisher Scientific (Waltham, MA, USA). Mouse monoclonal antibody against human CSE
(SC-365381) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Fetal bovine serum
(FBS), l-glutamine, streptomycin and penicillin were purchased from Biowest (Riverside, MO, USA).
Mini-PROTEAN TGX Stain-Free Precast Gels, the Clarity Western ECL substrate and the Laemmli
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protein sample buffer were purchased from Bio-Rad (Hercules, CA, USA). Bovine serum albumin was
purchased from AppliChem (Darmstadt, Germany).
2.2. Preparation of Sulfide Stock Solutions
Sulfide stock solutions were prepared by dissolving Na2S crystals in degassed ultra-pure (Milli-Q®,
Merck Millipore, Burlington, MA, USA) water under a N2 atmosphere, as reported in [63]. Sulfide
concentration was then measured spectrophotometrically with DTNB as reported in [64], using the
molar extinction coefficient ε412 = 14,150 M−1·cm−1 as recommended by the manufacturer. The
concentration of sulfide was then adjusted to 50 mM by dilution with degassed ultra-pure (Milli-Q®)
water in a gas-tight glass syringe. For simplicity, sulfide solutions, though containing H2S, HS− and
S2− in different proportions depending on the pH, here will be referred to as “H2S solutions”.
2.3. Cell Culture and Isolation of Mitochondria
SW480 colorectal cancer cells were cultured in DMEM containing 4.5 g·L−1 glucose, supplemented
with 2 mM l-glutamine, 10% (v/v) heat-inactivated FBS, 100 U·mL−1 penicillin and 100 µg·mL−1
streptomycin. For each studied condition, cells were seeded in five 25 cm2 flasks (1× 106 cells/flask) and
grown at 37 ◦C and 5% CO2. After 24 h, the culture medium was replaced with fresh medium (control)
or medium supplemented with 10 mM NAC, and further incubated for 24 h. After trypsinization,
cells were washed with fresh culture medium, counted using the trypan blue dye exclusion test, and
centrifuged at 1000× g for 5 min, yielding usually 2–3 × 107 cells per condition. Under the tested
conditions, 10 mM NAC proved not to be cytotoxic.
Mitochondrial preparations were obtained as described in [65] with modifications. The cell pellet
was washed twice in cold PBS, resuspended in 1 mL of hypotonic buffer (3.5 mM Tris-HCl pH 7.8,
2.5 mM NaCl, 0.5 mM MgCl2, 1% v/v protease inhibitors cocktail) and kept on ice for 1 h. The sample
was then transferred to a pre-chilled glass-teflon tissue grinder and homogenized with 100 strokes.
Immediately afterwards, 100 µL of hypertonic buffer (350 mM Tris-HCl pH 7.8, 250 mM NaCl, 50 mM
MgCl2) were added to the homogenate, which was carefully resuspended, followed by centrifugation
at 1000× g for 5 min at 4 ◦C to pellet unbroken cells, debris and nuclei. The supernatant was kept on
ice, while the pellet was resuspended in isotonic buffer (35 mM Tris-HCl pH 7.8, 25 mM NaCl, 5 mM
MgCl2, 1% protease inhibitor) and centrifuged a second time at 1000× g for 5 min at 4 ◦C, to minimize
heavy contaminants. The supernatants from both centrifugations were pooled and centrifuged at
20,000× g for 30 min at 4 ◦C. The mitochondria-enriched pellet was solubilized in 150 µL of 10 mM
Tris-HCl pH 7.4, 250 mM sucrose, 1 mM EDTA, 0.5% (w/v) N-lauryl maltoside, as reported in [66].
2.4. Human MST Expression and Purification
Recombinant human MST was expressed and purified as described in Yadav et al. [19].
2.5. SQR Activity Assay in Mitochondrial Preparations
The SQR activity assay was adapted from [67]. Measurements were carried out in a Cary 60
spectrophotometer (Agilent Technologies, Santa Clara, CA, USA) equipped with stirring and a Peltier
temperature control system. Assays were performed at 37 ◦C in a final volume of 1 mL. Briefly, 961 µL
of 100 mM potassium phosphate buffer at pH 7.5 were poured into a quartz cuvette, covered with
a 200 µL layer of mineral oil and degassed under a N2 atmosphere for a few minutes. The reaction
mixture contained 30 µL of mitochondrial extract (typically, in the range of 37.5–139 µg total protein),
58 µM CoQ1, 1 mM sodium sulfite, 2 mM sodium cyanide (to inhibit complex IV) and 4 µM rotenone (to
prevent H2S-derived reverse electron flow through complex I). The reaction was triggered by adding
96 µM H2S and the reaction rates were determined by following the reduction of CoQ1 at 278 nm
(∆εox-red = 12 mM−1cm−1). Data were normalized to total protein (quantified with the BCA method)
and were expressed as nmol of CoQ1 reduced per minute per mg of protein.
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2.6. MST Activity Assay in Cell Lysates
The MST activity was assayed in cell lysates as described in [68] with modifications. In the presence
of 3MP and a sulfur acceptor, MST produces H2S and pyruvate in a 1:1 stoichiometry. MST activity was
therefore evaluated by quantifying the amount of pyruvate produced over a given time (1 h) by MST
in the presence of an excess of the substrates. Pyruvate was quantified spectrophotometrically from
the amount of NADH enzymatically oxidized in the presence of LDH. Briefly, cells were harvested by
centrifugation and lysed using the CelLytic™MT reagent and the protease inhibitors cocktail from
Sigma, according to the manufacturer’s instructions. Cell lysates (typically, in the range of 0.56–0.36 mg
total protein) were dispensed into eppendorf tubes containing 100 mM Tris-HCl pH 8.0, 50 mM sodium
sulfite, 10 mM 2-mercaptoethanol (acting as a sulfur atom acceptor [19]) and 10 mM 3MP, in a final
volume of 1 mL. The eppendorf tubes were incubated at 37 ◦C in a thermal shaker for 1 h. Afterwards,
the reaction was stopped by addition of 446 mM PCA. The sample was kept on ice for 10 min, followed
by a 10-min centrifugation at 10,000× g at 4 ◦C and collection of the supernatant. Pyruvate in the
supernatant was then quantified by carrying out an LDH assay in a final volume of 1.095 mL at 37 ◦C.
The starting solution contained 100 mM Tris-HCl pH 8.0, 6.4 mM NEM, 224 µM NADH, and 50 µL of
the supernatant. NEM was present to block the residual 3MP which is also a substrate of LDH [68].
NADH oxidation was triggered by adding 7U LDH and followed as an absorbance decrease at 340 nm
(ε = 6.22 mM−1cm−1). Data were normalized to total protein content (quantified with BCA method)
and expressed as nmol of pyruvate generated per minute per mg of protein.
2.7. Recombinant Human MST Activity Assay
Activity assays on isolated recombinant human MST were adapted from [19,33,69]. The assays
were carried out in 96-well black plates, using the H2S-selective fluorescent probe 7AzC and a Thermo
Scientific Appliskan plate reader. The reaction mixture, in 200 mM Tris-HCl pH 8.0, contained 10 µg
of recombinant human MST per well, 50 µM 7AzC, and NAC (or Cys) at varied concentrations. The
reaction was triggered by adding 3MP in a total assay volume of 250 µL. The increase in fluorescence
(λex = 340 nm; λem = 460 nm) was monitored over 90 min at 37 ◦C. Kinetic parameters for Cys and
NAC were determined at concentrations ranging from 0 to 40 mM in the presence of 0.5 mM 3MP.
Conversely, kinetic parameters for 3MP were determined at concentrations ranging from 0 to 2 mM in
the presence of 20 mM NAC or Cys. Prior to use, the solutions of NAC, Cys and 3MP were adjusted to
pH 8.0 and their concentration determined by spectrophotometric titrations with DTNB, using the
molar extinction coefficient ε412nm = 14,150 M−1·cm−1. Data were analyzed using Excel and the MST
activity was calculated from the initial slope of the fluorescence increase.
2.8. Evaluation of Mitochondrial Content by the Citrate Synthase Assay
Cells were harvested and lysed as described in Section 2.6. Cell extracts were then assayed
spectrophotometrically for citrate synthase in 100 mM Tris-HCl, 0.3 mM acetyl-CoA, 0.1 mM DTNB
and 0.5 mM oxaloacetate, as described in [70].
2.9. Immunoblotting Assays
Cells were lysed as described in Section 2.6 and proteins quantified using the BCA method. Samples
were separated on SDS-PAGE Mini-PROTEAN TGX Stain-Free Precast Gels (Bio-Rad, Hercules, CA,
USA). The gel formulation includes trihalo compounds, which lead to UV fluorescence emission upon
reaction with proteins [71], allowing to estimate the total protein load in a gel lane for normalization
purposes, using a ChemiDoc MP imaging system (Bio-Rad, Hercules, CA, USA). After transfer onto
a PVDF membrane, proteins were blocked for 1 h with PBS-T (phosphate buffered saline with 0.1%
Tween 20 (v/v)) containing 3% bovine serum albumin (BSA, w/v) and then incubated overnight at 4 ◦C
with antibodies against human SQR or MST. After three washing steps with PBS-T, the membranes
were incubated for 1 h with horseradish peroxidase-conjugated secondary antibody, followed by
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three washing steps with PBS-T and detection by enhanced chemiluminescence (Clarity Western ECL
Substrate, Biorad, Hercules, CA, USA). Specific bands were analyzed using Image Lab software (Biorad,
Hercules, CA, USA), followed by normalization of the target protein band intensity to the total protein
load determined as described above.
2.10. NAC Quantification by Reverse Phase High Performance Liquid Chromatography (RP-HPLC)
This method was adapted from [72]. Cells were harvested as described in Section 2.3 and washed
twice in PBS. The pellet was resuspended in 250 µL ultra-pure (Milli-Q®) water, kept on ice for 30 min
and then lysed by three cycles of freeze-thawing. Lysates were mixed with 250 µL of 3.34% meta
phosphoric acid and, after vortexing, were incubated for 30 min on ice, followed by centrifugation at
12,000× g for 10 min at 4 ◦C. The supernatant was filtered and 120 µL of the deproteinized solution
were mixed with 60 µL of 0.3 M Na2HPO4 and 90 µL of 1 mM DTNB. NAC quantification was
performed at room temperature by injecting 100 µL of DTNB-derivatized samples into a PrevailTM C8
column (150 × 4.6 mm–5 µm) (Grace/Alltech, Columbia, MD, USA) connected to a double pump HPLC
apparatus (Azura ASM 2.1L; Knauer, Berlin, Germany) equipped with an UV-Vis detector (Azura
ASM 2.1L; Knauer, Berlin, Germany). Injections were performed automatically using an HT300L
autosampler (HTA). The elution was monitored by recording the signal at 331 nm using the following
mobile phase: 20 mM NaH2PO4 pH 4.9 (Buffer A) and 100% methanol (Buffer B). The flow rate was
1 mL·min−1 and the concentration of buffer B was varied during the elution as follows: 2% B for
10 mL, then the concentration of B was raised to 40% in a steep gradient of 2 mL, kept at 40% for
1 mL to allow the elution of the unreacted excess of DTNB, then brought back to 2% in a 2 mL reverse
gradient and kept at 2% for 7 mL before injection of the next sample. Calibrations were performed by
injecting standards of NAC, GSH and Cys at known concentrations after derivatization with DTNB.
For each condition, two experimental duplicates were tested, and each duplicate was injected twice.
The derivatization buffer and a derivatized lysate of untreated cells were injected as controls.
3. Results
3.1. Effect of NAC on Expression Levels of H2S Metabolism Enzymes
SW480 colorectal cancer cells were grown in DMEM alone or supplemented with 10 mM NAC.
After 24 h, the expression levels of CBS, CSE, MST and SQR were evaluated in the cell lysates by
immunoblotting. Whereas cell exposure to NAC had no effect on the expression of CBS and CSE
(Supplementary Figure S1), as compared to control cells, NAC-treated cells displayed increased
expression of both MST isoforms (overall accounting for an increment of 61 ± 16%, Figure 1A,B)
and SQR (by 36 ± 1%, Figure 1C,D). In a control experiment with cells grown for 24 h in DMEM
supplemented with 10 mM Cys instead of NAC, a decrease in both MST and SQR expression (by 24 ±
10% and 28 ± 9%, respectively) was observed (Supplementary Figure S2). As compared to the control,
NAC did not affect cellular viability and proliferation, while treatment with cysteine proved to be
cytotoxic at the tested conditions, causing impairment of cellular growth of ≈30%.
3.2. Effect of NAC on MST Activity
Prompted by the increased MST expression levels observed upon cell exposure to NAC, we
evaluated the MST activity in lysates of NAC-treated cells. As described in Section 2.6, the activity was
evaluated by quantifying spectrophotometrically in an LDH-coupled assay the amount of pyruvate
produced over 1 h by MST in the presence of excess of 3MP and 2-mercaptoethanol. A representative
trace of pyruvate quantitation is shown in Figure 2A. In the assay, the starting solution contained a
diluted aliquot of the deproteinized MST reaction mixture with the produced pyruvate, and NEM to
block unreacted 3MP. As expected, the absorbance at 340 nm increased after addition of NADH. Upon
addition of LDH, partial oxidation of NADH was detected as an absorbance decrease, and pyruvate
could be quantified from the NADH being oxidized. In line with their enhanced MST expression levels,
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NAC-treated cells displayed higher MST activity than control cells (112.4 ± 9.5 nmol·min−1·mg−1 vs.
92.1 ± 7.9 nmol·min−1·mg−1, Figure 2B). A blank control lacking the MST reaction mixture, and thus
pyruvate, exhibited no changes in absorbance upon addition of LDH (not shown).Cells 2019, 8, x FOR PEER REVIEW 7 of 18 
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Western blot analysis of SQR expression. (Panel D) SQR expression levels as normalized to total 
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≤ 0.05. 
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Figure 1. Effect of AC on MST and SQR expression. (Panel A) Representative Western blot analysis of
MST expression in SW480 cells grown for 24 h in DME alone (control) or supplemented with 10 mM
NAC (NAC). The blots are shown together with their corresponding total protein load quantitation
by stain-free imaging technology (see Materials and Methods). (Panel B) MST expression levels as
normalized to total protein. Data represent the mean value ± SEM of 6 repeats, each carried out in
technical duplicate. *** p ≤ 0.001. (Panel C) Similarly to panel A, representative Western blot analysis
of SQR expression. (Panel D) SQR expression levels as normalized to total protein. Data represent the
mean value ± SEM of 5 repeats, each carried out in technical duplicate. * p ≤ 0.05.
3.3. Effect of NAC on SQR Activity
The H2S oxidizing activity of SQR was evaluated in mitochondrial preparations of NAC-treated
and control cells by monitoring spectrophotometrically the H2S-induced reduction of exogenous
CoQ1 (see Section 2.5). The efficiency of mitochondria isolation was preliminarily confirmed with
immunoblotting assays revealing the presence of SQR in the mitochondrial preparations, but not
(at least to detectable levels) in the cytosolic fraction (Supplementary Figure S3). A representative
SQR activity assay is shown in Figure 3A. The mitochondrial preparation was preincubated with
the mitochondrial electron transport chain inhibitors rotenone and cyanide, respectively to prevent
re-oxidation of the reduced CoQ1 by Complex I through reverse electron transfer [28] or by Complex
III and IV through forward electron transfer to O2 [67]. The SQR-mediated H2S:CoQ1 oxidoreductase
activity of NAC-treated cells was 25.8 ± 2.7 nmol·min−1·mg−1, whereas that of untreated cells was 17.2
± 4.6 nmol·min−1·mg−1 (Figure 3B). A blank control lacking the mitochondrial extract exhibited no
changes in absorbance upon addition of H2S (not shown).
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Figure 2. MST activity in cell lysates. (Panel A) Representative spectrophotometric trace of MST activity
measured by LDH-coupled assay. The measurement was carried out at 37 ◦C under stirring conditions
(see Materials and Methods). The starting solution contained the deproteinized MST activity mixture in
Tris-HCl 100 mM (pH 8.0) containing 6.4 mM NEM to block unreacted 3MP. After addition of 224 µM
NADH followed by addition of 7 U LDH, the pyruvate concentration was estimated from the NADH
being oxidized accounting for the decrease in absorbance measured at 340 nm. (Panel B) MST activity
normalized to total protein. Data represent the mean value ± SD of 5 repeats. ** p ≤ 0.01.
Cells 2019, 8, x FOR PEER REVIEW 8 of 18 
 
 
Figure 2. MST activity in cell lysates. (Panel A) Representative spectrophotometric trace of MST 
activity measured by LDH-coupled assay. The measurement was carried out at 37 °C under stirring 
conditions (see Materials and Methods). The starting solution contained the deproteinized MST 
activity mixture in Tris-HCl 100 mM (pH 8.0) containing 6.4 mM NEM to block unreacted 3MP. After 
addition of 224 μM NADH followed by addition of 7 U LDH, the pyruvate concentration was 
estimated from the NADH being oxidized accounting for the decrease in absorbance measured at 340 
nm. (Panel B) MST activity normalized to total protein. Data represent the mean value ± SD of 5 
repeats. ** p ≤ 0.01. 
3.3. Effect of NAC on SQR Activity 
The H2S oxidizing activity of SQR was evaluated in mitochondrial preparations of NAC-treated 
and control cells by monitoring spectrophotometrically the H2S-induced reduction of exogenous 
CoQ1 (see Section 2.5). The efficiency of mitochondria isolation was preliminarily confirmed with 
immunoblotting assays revealing the presence of SQR in the mitochondrial preparations, but not (at 
least to detectable levels) in the cytosolic fraction (Supplementary Figure S3). A representative SQR 
activity assay is shown in Figure 3A. The mitochondrial preparation was preincubated with the 
mitochondrial electron transport chain inhibitors rotenone and cyanide, respectively to prevent 
re-oxidation of the reduced CoQ1 by Complex I through reverse electron transfer [28] or by Complex 
III and IV through forward electron transfer to O2 [67]. The SQR-mediated H2S:CoQ1 oxidoreductase 
activity of NAC-treated cells was 25.8 ± 2.7 nmol·min−1·mg−1, whereas that of untreated cells was 17.2 
± 4.6 nmol·min−1·mg−1 (Figure 3B). A blank control lacki g the mitochondrial extract exhibited no 
changes in absorban e upo  addition of H2S (not shown). 
 
Figure 3. SQR activity of mitochondrial extracts. (Panel A) Representative spectrophotometric trace 
of SQR activity. The measurement was carried out at 37 °C under stirring. The starting solution 
Figure 3. SQR activity of mitochondrial extracts. (Panel A) Representative spectrophotometric trace
of SQR activity. The measurement was carried out at 37 ◦C under stirring. The starting solution
contained the mitochondrial protein extra t in 100 mM potassium phosphate buffer (pH 7.5) in anaer bic
conditions (see Materials and Methods). Then, 58 µM CoQ1, 1 mM sodium sulfite, 2 mM sodium
cyanide and 4 µM rotenone were sequentially added. SQR enzymatic activity was triggered by
adding 96 µM H2S, and the reaction rate was estimated by following the reduction of CoQ1 at 278
nm. Afterwards, CoQ1 was fully reduced by addition of dithiothreitol (DTT). (Panel B) SQR activity
normalized to total protein. Data represent the mean value ± SD of 5 repeats. ** p ≤ 0.01.
3.4. Effect of NAC on Mitochondrial Mass
Citrate synthase (CS) activity measurements were carried out as a validated surrogate marker of
mitochondrial mass [70]. NAC-treated and control cells exhibited very similar CS activity (respectively
11.3 ± 1.4 µM·min−1·mg −1 and 10.4 ± 1.9 µM·min−1·mg−1, Figure S4).
3.5. Kinetics of H2S Production by Recombinant Human MST with NAC as a Substrate
The H2S-synthesizing activity of recombinant human MST was evaluated in the presence of 3MP
using the H2S selective fluorescent probe 7AzC [69]. In these assays, the ability of NAC to function
as a substrate for MST was evaluated in comparison with Cys, a known physiological substrate of
the enzyme [19]. The KM and Vmax values for NAC or Cys were independently determined at fixed
concentration of 3MP. A hyperbolic dependence of MST activity on the substrate concentration was
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observed for both NAC and Cys (Figure 4A). Accordingly, data were fitted to the Michaelis-Menten
model, yielding the apparent KM and Vmax values reported in Table 1. As compared to Cys, NAC
yielded a 2.5-fold higher Vmax and a 1.9-fold higher KM, thereby accounting for a 1.3-fold higher
catalytic efficiency (Vmax/KM). To evaluate the effect on MST activity of the simultaneous presence of
the two substrates, H2S production by MST was determined in the presence of Cys and NAC together.
As shown in Figure S5, no significant changes in the enzyme activity were observed in the presence of
both Cys and NAC, as compared to NAC alone. With either NAC or Cys at saturating concentrations,
MST activity displayed clear sigmoidal dependence on 3MP concentration (Figure 4B), and both the
Vmax and KM values for 3MP were in the same order of magnitude (Table 1). In these assays too, NAC
was confirmed to account for a higher catalytic efficiency (1.4-fold), as compared to Cys.Cells 2019, 8, x FOR PEER REVIEW 10 of 18 
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Figure 4. Kinetics of H2S generation by MST. (Panel A) H2S-synthesizing activity of MST measured at
varying concentrations of Cys or NAC. The reaction mixture contained 10 µg recombinant human MST,
0–40 mM NAC (blue) or Cys (green), 50 µM 7AzC and 0.5 mM 3MP in a total assay volume of 250 µL, as
described in Materials and Methods. Buffer: 200 mM Tris-HCl pH 8.0 Data represent the mean values
± SD of at least two independent experiments, each in technical triplicate. (Panel B) H2S-synthesizing
activity of MST measured at varying concentrations of 3MP. The reaction mixture contained 0–2 mM
3MP, 20 mM of NAC (blue) or Cys (green). Other experimental conditions as reported in panel A. Data
represent the mean values ± SD of at least two independent experiments, each in technical triplicate.
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Table 1. Kinetic parameters of human MST.
KM (A) Vmax (A) Vmax/KM (A) KM (3MP) Vmax (3MP) Vmax/KM (3MP)
mM RFU·min−1 RFU·min−1·mM−1 mM RFU·min−1 RFU·min−1·mM−1
Cys 6.0 ± 1.0 15,136 ± 839 2523 0.57 ± 0.04 81,560 ± 3972 143,088
NAC 11.4 ± 1.0 37,178 ± 1442 3261 0.49 ± 0.02 95,396 ± 2487 194,686
(A) Values determined at varying concentration of Cys or NAC and fixed concentration of 3MP. (3MP) Values
determined at varying concentration of 3MP and fixed concentration of either Cys or NAC.
3.6. HPLC Quantification of Intracellular NAC
SW480 cells were treated with DMEM supplemented with 10 mM NAC for 5 min, 2 h, 6 h or 24 h.
After harvesting, cell lysates were deproteinized and thiol compounds were derivatized with DTNB. In
each sample, NAC was determined simultaneously with Cys and GSH by using a simple and sensitive
RP-HPLC method (Figure 5A), as reported in the Materials and Methods (Section 2.10). For each
analyte, the calibration curves were linear at least up to 120 µM. Under the working conditions, NAC
displayed good stability and a retention time (about 7 min) sufficiently distinct from those of Cys and
GSH (about 3 min and 5 min, respectively). No significant interference from endogenous substances
was observed at the retention times of the studied compounds. As shown in Figure 5B, under the tested
conditions, the intracellular levels of NAC remained detectable and essentially constant from 2 to 24 h.
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Figure 5. Intracellular NAC quantification by RP-HPLC. (Panel A) SW480 colon cancer cells were
treated with 10 mM NAC for 5 min, 2 h, 6 h and 24 h. Cell lysates were deproteinized and NAC was
quantified by RP-HPLC simultaneously with Cys and GSH after DTNB derivatization. Representative
chromatograms are shown. Calibrations (in gray) were performed by injecting standard solutions of
GSH, Cys and NAC at known concentrations. In black it is reported a representative chromatogram
obtained with cells treated with NAC for 24 h. (Panel B) Data represent the mean values ± SD of two
biological duplicates, each in technical duplicate.
4. Discu sion
Several lines of evidence have shown that mitochondrial dysfunction is interrelated with cancer
hallmarks, such as metastatic propensity, cell death evasion, dysregulated bioenergetics and genome
instability (reviewed in [44]). Altered redox balance is a common feature to cancer cells, which usually
exhibit persist ntly high ROS le ls in comparison to their normal counterparts [73]. Cancer ells a e
therefore endowed with n enhanced antioxi ant system, which protects them from oxidative damage
and likely contributes to drug resistance [74]. ROS modulation has long ppeared as a possible strategy
to fight cancer by either preventing maligna t transformation or killing cancerous cells. However, the
consequences f pharmacological ROS modulation in vivo are hard to predict [73]. While it has been
propos d that targeting ROS with antioxidant compounds could prevent carcinogenesis, upregulation
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of ROS by anticancer drugs does suppress vulnerable cancer cells, but it also affects normal tissues,
thereby contributing to the several side-effects typically associated with antitumoral chemotherapy.
Reprogramming of sulfur metabolism has been reported as a common mechanism to different
cancer types (reviewed in [2,75]). In cancer cells, enzymes involved in H2S synthesis, such as CBS,
CSE and MST [76] were found to be overexpressed [36,37,39–41,77,78], and growing evidence suggests
that H2S and related reactive sulfide species, including sulfane sulfur species, play a role in cancer
biology [9,34]. While H2S appears to favor cancer cell survival and proliferation by stimulating cell
bioenergetics and neo-angiogenesis, among other effects, sulfane sulfur species could potentiate the cell
antioxidant defense system, by both scavenging free radicals and enhancing the activity of antioxidant
enzymes such as glutathione peroxidase, glutathione reductase and superoxide dismutase [79,80].
(Per/poly)sulfides are indeed more nucleophilic than the corresponding thiols and their reactivity
towards ROS increases with the length of the sulfane sulfur chain [14]. In this context, it is of relevance
that NAC, a commonly used antioxidant drug, was recently proposed to exert its antioxidant activity
precisely by promoting sulfane sulfur production [62,81,82]. Therefore, while NAC supplementation
may appear as an appealing strategy to ameliorate the oxidative stress imposed by alkylating/oxidative
chemotherapeutic drugs, chronic exposure to NAC may actually confer unwanted protective effects to
cancer cells.
In the present study, working on SW480 colorectal cancer cells, we explored the effect of prolonged
(24 h) exposure to NAC on H2S metabolism, particularly on its synthases (CBS, CSE and MST) and
SQR, the enzyme catalyzing the limiting step of mitochondrial sulfide oxidation. Cell exposure to NAC
resulted in increased expression levels of both MST (≈60%) (Figure 1B) and SQR (≈40%) (Figure 1D),
whereas neither CBS nor CSE expression levels varied significantly (Figure S1). Such changes in protein
expression were not observed when cells were exposed to Cys in place of NAC under otherwise
identical experimental conditions (Figure S2), which argues against the idea that the observed effects
are due to the Cys derived from intracellular NAC deacetylation [83,84]. This was further corroborated
by the observation that, while NAC treatment did not affect the cellular proliferation rate, exposure
to cysteine resulted in ≈30% decreased cell viability. This observation neatly fits with the reported
cytotoxicity of cysteine both in cell culture media [85,86] and as a dietary supplement of animal models,
particularly as compared to N-acetylcysteine [87]. In this respect, the downregulation of both MST and
SQR could be related to the cysteine-mediated cytotoxicity.
The NAC-induced enhancement of MST and SQR expression levels points to changes in
mitochondrial H2S metabolism. With the aim of exploring the correlation between increased expression
levels and enzymatic activity, a functional approach was undertaken by measuring MST and SQR
activity in cell and mitochondrial extracts, respectively. As compared to controls, NAC-treated cells
displayed, respectively, ≈20% and ≈50% increase in MST and SQR activity (Figures 2B and 3B), in line
with the increased expression levels of these enzymes. Considering that NAC exposure did not result
in changes in the mitochondrial mass (Figure S4), NAC seems to induce a mitochondrial enrichment in
SQR and possibly MST, likely boosting the mitochondrial (per/poly)sulfide metabolism. In agreement
with a previous report [62], we speculate that the enhanced production of mitochondrial reactive
sulfide species and their physical proximity to the electron transport chain, a main source of ROS,
could be at the basis of the antioxidant function of NAC.
Besides the regulatory effect of NAC on MST and SQR expression, we tested whether NAC
could stimulate the production of sulfane sulfur species by directly sustaining MST activity, acting
as a sulfane sulfur accepting co-substrate, similarly to Cys or homocysteine [19]. Working on the
recombinant human MST, we found that the enzyme can use NAC as a substrate to sustain H2S
synthesis with a higher KM but also a higher Vmax when compared to Cys, overall accounting for a
≈30% higher catalytic efficiency (Vmax/KM) (Table 1). This higher catalytic efficiency was confirmed
by measuring the enzymatic activity at varied 3MP concentrations and fixed concentration of NAC
(Figure 4B; Table 1). Combined NAC and Cys acting as sulfane sulfur acceptors yielded a comparable
MST activity to that measured with NAC alone, approximately the double of the activity with Cys alone
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(Figure S5). Therefore, NAC and Cys do not display synergic or additive effects on H2S generation
by MST and probably compete for the same binding site on the protein. Given the higher reactivity
of (per/poly)sulfides with electrophiles compared to their thiolic counterpart [15,88,89], it is likely
that NAC persulfide (N-AceCysSSH)—the expected product of the reaction of MST with NAC—can
directly contribute to ROS scavenging, as already reported for cysteine persulfide (CysSSH, [80]). It is
important to note that, in addition to affording protection from oxidative stress, N-AceCysSSH may
also increase the drug detoxifying capacity of cancer cells, thus promoting chemoresistance. Indeed,
acetylation of cysteine-S-drug conjugates by microsomal NAT8 into the corresponding mercapturate is
a crucial step for drug excretion in the urine [16,17]. On this basis, it is envisaged that conjugation of
MST-derived N-AceCysSSH with an exogenous alkylating/oxidative drug will prompt the latter for its
excretion. Therefore, our results suggest that NAC supplementation may help cancer cells not only
evade the oxidative stress derived from anticancer drug, but even increase their drug resistance.
The physiological relevance of the reaction between NAC and MST might be questioned because
cell-internalized NAC was reported to be deacetylated into cysteine [83,84], though at significant rates
only in kidneys and much less in other organs [84]. To address this question, we evaluated the residual
amount of NAC in treated SW480 cells by RP-HPLC at different exposure times to NAC and found that,
under our working conditions, the intracellular levels of NAC remained detectable and essentially
constant over at least 24 h-treatment (Figure 5B). This shows that in our experimental setting, despite
possible reactions with acylases, NAC persists as such inside the cells for a considerable time, allowing
its reaction with MST and other protein targets.
In summary, this is to our knowledge the first study in which the effect of prolonged cell exposure
to NAC on H2S metabolism has been evaluated in colon cancer cells. The evidence collected with
SW480 colorectal cancer cells shows that: (i) treatment with NAC promotes increased expression and
activity of mitochondrial enzymes (MST and SQR) involved in the production and consumption of
H2S and sulfane sulfur species and (ii) NAC can act as a direct sulfane sulfur-accepting co-substrate
for MST, being likely persulfidated (Figure 6). The relevance of these findings in cancer biology needs
to be assessed, particularly whether the ability of colorectal cells to resist oxidative stress and develop
chemoresistance could be promoted by NAC through mitochondrial metabolic reprogramming of H2S
and related reactive species.
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CSE: cystathionine γ-lyase; MST: 3-mercaptopyruvate sulfurtransferase; 3MP: 3-mercaptopyruvate;
SQR: sulfide:quinone oxidoreductase; GSSH: glutathione persulfide; ROS: reactive oxygen species;
Cys-SSH: cysteine persulfide; N-AceCysSSH: N-acetylcysteine persulfide.
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